The valuation of Medtronic plc has remained largely flat for roughly the last three years, since shortly after it completed the massive almost $50 billion acquisition of Covidien plc at the end of January 2015. But now that it has absorbed that company, the Dublin-based med-tech behemoth is focused on getting credit for its efforts from investors. Read More
